Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (F H ...

Monoclonal antibodies have specificity for a particular antigen (target of antibodies), but polyclonal ones are not specific to any antigen. Recombinant ones are monoclonal, and here are the key ...

Blinatumomab is a bispecific T cell engager (BiTE) antibody construct to treat adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL).

European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) ...